{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients aged at least 18 years, who were scheduled for elective colorectal cancer surgery through a midline incision at two Swedish hospitals (2017\u20132021), were randomized in a 1 : 1 ratio"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients aged at least 18 years, who were scheduled for elective colorectal cancer surgery through a midline incision at two Swedish hospitals (2017\u20132021)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized in a 1 : 1 ratio to either fascial closure with RTL and 4 : 1 small-bite closure with polypropylene sutures (RTL group) or 4 : 1 small-bite closure with polydioxanone suture alone (PDS group)"
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim was to investigate whether adding a reinforced tension-line (RTL) suture to a standard 4 : 1 small-bite closure would reduce the incidence of incisional hernia after colorectal cancer surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was CT-detected incisional hernia 1 year after surgery."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomized in a 1 : 1 ratio"
      },
      "Blinding": {
        "score": 1,
        "evidence": "CT interpreters were blinded regarding treatment group."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "In all, 160 patients were randomized, 80 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Some 134 patients were analysed at 1 year: 63 in the RTL group and 71 in the PDS group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Nineteen patients were found to have an incisional hernia: 4 (6%) in the RTL group and 15 (21%) in the PDS group (OR 3.95, 95% c.i. 1.24 to 12.60; P = 0.014)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No unintended effects were found in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03390764 ( https://clinicaltrials.gov )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}